Katja Shipp

I joined the Nuffield Department of Women’s and Reproductive Health in July 2022 as a research midwife for the Oxford Safer Pregnancy Alliance (OSPREA), now known as CRG (Clinical Research Group). Prior to this role, I spent 12 years working as a qualified midwife, primarily at the Women’s Centre, John Radcliffe Hospital, Oxford.

In addition to my midwifery experience, I qualified as a nurse in 2001 and worked in Germany, then spent time living and working in Cambodia from 2009 to 2011. I completed my midwifery qualification in 2013 at Oxford Brookes University and have since worked as a clinical midwife in both Germany and England. My additional roles have included working as a Team Leader in general nursing, counselling pregnant women in the ‘Birth Choices Clinic’, and mentoring many student midwives.

Since transitioning to research, I have contributed to a range of secondary setting clinical trials, both with and without CTIMP, including: COPE, SMA, PANDA-DOSE, CAPE, PANDA WS3. I led the Harmonie vaccination study, for which I received an individual OU Recognition Award in May 2023. I have also been involved and successful in contributing to the OxPLUS Sonography study, PROTECT (Pregnancy outcomes using continuous glucose monitoring technology in pregnant women with early-onset Type 2 diabetes), and STOPPIT 3 (randomised placebo-controlled trial of antenatal corticosteroids for planned birth in twins). Currently, I have also taken on the role of leading MAMA (The Monoclonal Antibody Medications in inflammatory Arthritis: stopping or continuing in pregnancy). Since April 2025, I have been facilitating FREESIA-3, a role in which I am able to apply and further develop my nursing, midwifery, and research skills.

In June 2023, I successfully completed the OU Clinical Trial Management Course.